purchase customization

Leave This Empty:

choose chapter to purchase

table of content

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Adipose Tissue-derived Stem Cell Therapy
1.2 Key Market Segments
1.2.1 Adipose Tissue-derived Stem Cell Therapy Segment by Type
1.2.2 Adipose Tissue-derived Stem Cell Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Adipose Tissue-derived Stem Cell Therapy Market Overview
2.1 Global Market Overview
2.1.1 Global Adipose Tissue-derived Stem Cell Therapy Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Adipose Tissue-derived Stem Cell Therapy Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Adipose Tissue-derived Stem Cell Therapy Market Competitive Landscape
3.1 Global Adipose Tissue-derived Stem Cell Therapy Sales by Manufacturers (2019-2024)
3.2 Global Adipose Tissue-derived Stem Cell Therapy Revenue Market Share by Manufacturers (2019-2024)
3.3 Adipose Tissue-derived Stem Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Adipose Tissue-derived Stem Cell Therapy Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Adipose Tissue-derived Stem Cell Therapy Sales Sites, Area Served, Product Type
3.6 Adipose Tissue-derived Stem Cell Therapy Market Competitive Situation and Trends
3.6.1 Adipose Tissue-derived Stem Cell Therapy Market Concentration Rate
3.6.2 Global 5 and 10 Largest Adipose Tissue-derived Stem Cell Therapy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Adipose Tissue-derived Stem Cell Therapy Industry Chain Analysis
4.1 Adipose Tissue-derived Stem Cell Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Adipose Tissue-derived Stem Cell Therapy Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Adipose Tissue-derived Stem Cell Therapy Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Adipose Tissue-derived Stem Cell Therapy Sales Market Share by Type (2019-2024)
6.3 Global Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Type (2019-2024)
6.4 Global Adipose Tissue-derived Stem Cell Therapy Price by Type (2019-2024)
7 Adipose Tissue-derived Stem Cell Therapy Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Adipose Tissue-derived Stem Cell Therapy Market Sales by Application (2019-2024)
7.3 Global Adipose Tissue-derived Stem Cell Therapy Market Size (M USD) by Application (2019-2024)
7.4 Global Adipose Tissue-derived Stem Cell Therapy Sales Growth Rate by Application (2019-2024)
8 Adipose Tissue-derived Stem Cell Therapy Market Segmentation by Region
8.1 Global Adipose Tissue-derived Stem Cell Therapy Sales by Region
8.1.1 Global Adipose Tissue-derived Stem Cell Therapy Sales by Region
8.1.2 Global Adipose Tissue-derived Stem Cell Therapy Sales Market Share by Region
8.2 North America
8.2.1 North America Adipose Tissue-derived Stem Cell Therapy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Adipose Tissue-derived Stem Cell Therapy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Adipose Tissue-derived Stem Cell Therapy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Adipose Tissue-derived Stem Cell Therapy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Adipose Tissue-derived Stem Cell Therapy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 AlloCure
9.1.1 AlloCure Adipose Tissue-derived Stem Cell Therapy Basic Information
9.1.2 AlloCure Adipose Tissue-derived Stem Cell Therapy Product Overview
9.1.3 AlloCure Adipose Tissue-derived Stem Cell Therapy Product Market Performance
9.1.4 AlloCure Business Overview
9.1.5 AlloCure Adipose Tissue-derived Stem Cell Therapy SWOT Analysis
9.1.6 AlloCure Recent Developments
9.2 Antria
9.2.1 Antria Adipose Tissue-derived Stem Cell Therapy Basic Information
9.2.2 Antria Adipose Tissue-derived Stem Cell Therapy Product Overview
9.2.3 Antria Adipose Tissue-derived Stem Cell Therapy Product Market Performance
9.2.4 Antria Business Overview
9.2.5 Antria Adipose Tissue-derived Stem Cell Therapy SWOT Analysis
9.2.6 Antria Recent Developments
9.3 Celgene Corporation
9.3.1 Celgene Corporation Adipose Tissue-derived Stem Cell Therapy Basic Information
9.3.2 Celgene Corporation Adipose Tissue-derived Stem Cell Therapy Product Overview
9.3.3 Celgene Corporation Adipose Tissue-derived Stem Cell Therapy Product Market Performance
9.3.4 Celgene Corporation Adipose Tissue-derived Stem Cell Therapy SWOT Analysis
9.3.5 Celgene Corporation Business Overview
9.3.6 Celgene Corporation Recent Developments
9.4 Cellleris
9.4.1 Cellleris Adipose Tissue-derived Stem Cell Therapy Basic Information
9.4.2 Cellleris Adipose Tissue-derived Stem Cell Therapy Product Overview
9.4.3 Cellleris Adipose Tissue-derived Stem Cell Therapy Product Market Performance
9.4.4 Cellleris Business Overview
9.4.5 Cellleris Recent Developments
9.5 Corestem
9.5.1 Corestem Adipose Tissue-derived Stem Cell Therapy Basic Information
9.5.2 Corestem Adipose Tissue-derived Stem Cell Therapy Product Overview
9.5.3 Corestem Adipose Tissue-derived Stem Cell Therapy Product Market Performance
9.5.4 Corestem Business Overview
9.5.5 Corestem Recent Developments
9.6 Cytori Therapeutics
9.6.1 Cytori Therapeutics Adipose Tissue-derived Stem Cell Therapy Basic Information
9.6.2 Cytori Therapeutics Adipose Tissue-derived Stem Cell Therapy Product Overview
9.6.3 Cytori Therapeutics Adipose Tissue-derived Stem Cell Therapy Product Market Performance
9.6.4 Cytori Therapeutics Business Overview
9.6.5 Cytori Therapeutics Recent Developments
9.7 Intrexon
9.7.1 Intrexon Adipose Tissue-derived Stem Cell Therapy Basic Information
9.7.2 Intrexon Adipose Tissue-derived Stem Cell Therapy Product Overview
9.7.3 Intrexon Adipose Tissue-derived Stem Cell Therapy Product Market Performance
9.7.4 Intrexon Business Overview
9.7.5 Intrexon Recent Developments
9.8 Mesoblast
9.8.1 Mesoblast Adipose Tissue-derived Stem Cell Therapy Basic Information
9.8.2 Mesoblast Adipose Tissue-derived Stem Cell Therapy Product Overview
9.8.3 Mesoblast Adipose Tissue-derived Stem Cell Therapy Product Market Performance
9.8.4 Mesoblast Business Overview
9.8.5 Mesoblast Recent Developments
9.9 Pluristem Therapeutics
9.9.1 Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Basic Information
9.9.2 Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Product Overview
9.9.3 Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Product Market Performance
9.9.4 Pluristem Therapeutics Business Overview
9.9.5 Pluristem Therapeutics Recent Developments
9.10 Tissue Genesis
9.10.1 Tissue Genesis Adipose Tissue-derived Stem Cell Therapy Basic Information
9.10.2 Tissue Genesis Adipose Tissue-derived Stem Cell Therapy Product Overview
9.10.3 Tissue Genesis Adipose Tissue-derived Stem Cell Therapy Product Market Performance
9.10.4 Tissue Genesis Business Overview
9.10.5 Tissue Genesis Recent Developments
9.11 BioRestorative Therapies
9.11.1 BioRestorative Therapies Adipose Tissue-derived Stem Cell Therapy Basic Information
9.11.2 BioRestorative Therapies Adipose Tissue-derived Stem Cell Therapy Product Overview
9.11.3 BioRestorative Therapies Adipose Tissue-derived Stem Cell Therapy Product Market Performance
9.11.4 BioRestorative Therapies Business Overview
9.11.5 BioRestorative Therapies Recent Developments
9.12 Celltex Therapeutics Corporation
9.12.1 Celltex Therapeutics Corporation Adipose Tissue-derived Stem Cell Therapy Basic Information
9.12.2 Celltex Therapeutics Corporation Adipose Tissue-derived Stem Cell Therapy Product Overview
9.12.3 Celltex Therapeutics Corporation Adipose Tissue-derived Stem Cell Therapy Product Market Performance
9.12.4 Celltex Therapeutics Corporation Business Overview
9.12.5 Celltex Therapeutics Corporation Recent Developments
9.13 iXCells Biotechnologies
9.13.1 iXCells Biotechnologies Adipose Tissue-derived Stem Cell Therapy Basic Information
9.13.2 iXCells Biotechnologies Adipose Tissue-derived Stem Cell Therapy Product Overview
9.13.3 iXCells Biotechnologies Adipose Tissue-derived Stem Cell Therapy Product Market Performance
9.13.4 iXCells Biotechnologies Business Overview
9.13.5 iXCells Biotechnologies Recent Developments
9.14 Pluristem Therapeutics
9.14.1 Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Basic Information
9.14.2 Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Product Overview
9.14.3 Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Product Market Performance
9.14.4 Pluristem Therapeutics Business Overview
9.14.5 Pluristem Therapeutics Recent Developments
9.15 Cyagen
9.15.1 Cyagen Adipose Tissue-derived Stem Cell Therapy Basic Information
9.15.2 Cyagen Adipose Tissue-derived Stem Cell Therapy Product Overview
9.15.3 Cyagen Adipose Tissue-derived Stem Cell Therapy Product Market Performance
9.15.4 Cyagen Business Overview
9.15.5 Cyagen Recent Developments
9.16 Lonza
9.16.1 Lonza Adipose Tissue-derived Stem Cell Therapy Basic Information
9.16.2 Lonza Adipose Tissue-derived Stem Cell Therapy Product Overview
9.16.3 Lonza Adipose Tissue-derived Stem Cell Therapy Product Market Performance
9.16.4 Lonza Business Overview
9.16.5 Lonza Recent Developments
10 Adipose Tissue-derived Stem Cell Therapy Market Forecast by Region
10.1 Global Adipose Tissue-derived Stem Cell Therapy Market Size Forecast
10.2 Global Adipose Tissue-derived Stem Cell Therapy Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Adipose Tissue-derived Stem Cell Therapy Market Size Forecast by Country
10.2.3 Asia Pacific Adipose Tissue-derived Stem Cell Therapy Market Size Forecast by Region
10.2.4 South America Adipose Tissue-derived Stem Cell Therapy Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Adipose Tissue-derived Stem Cell Therapy by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Adipose Tissue-derived Stem Cell Therapy Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Adipose Tissue-derived Stem Cell Therapy by Type (2025-2030)
11.1.2 Global Adipose Tissue-derived Stem Cell Therapy Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Adipose Tissue-derived Stem Cell Therapy by Type (2025-2030)
11.2 Global Adipose Tissue-derived Stem Cell Therapy Market Forecast by Application (2025-2030)
11.2.1 Global Adipose Tissue-derived Stem Cell Therapy Sales (Kilotons) Forecast by Application
11.2.2 Global Adipose Tissue-derived Stem Cell Therapy Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings